Does MTHFD1 rs2236225 predispose to macrocytosis by reducing folate-cycle efficiency?

The MTHFD1 rs2236225 (G1958A) polymorphism is a significant genetic factor that influences the efficiency of the folate cycle, potentially predisposing individuals to hematological changes such as macrocytosis when folate intake is suboptimal.

Mechanistic basis of MTHFD1 rs2236225

The MTHFD1 gene encodes a trifunctional enzyme critical for generating 1-carbon derivatives necessary for the de novo synthesis of thymidylate and purines.

• Enzyme Stability: The rs2236225 (G1958A) variant results in a p.R653Q amino acid substitution that destabilizes the MTHFD1 protein. This structural instability reduces the metabolic efficiency of the folate cycle.
• Folate Homeostasis: Because this enzyme is central to folate utilization, individuals carrying the variant show altered folate handling. Carriers of the A allele or specific homozygous genotypes (depending on the population) have been found to have lower serum folate levels and a heightened sensitivity to dietary folate deficiency.
• Downstream Synthesis: Reduced MTHFD1 activity limits the availability of 5,10-methylenetetrahydrofolate, a necessary cofactor for thymidylate synthase to convert dUMP to dTMP. This step is the rate-limiting bottleneck for DNA replication.

Pathogenesis of macrocytosis

When folate-cycle efficiency is compromised, either through genetic variants like rs2236225 or low dietary intake, it directly impacts erythropoiesis.

• Nuclear-Cytoplasmic Asynchrony: In red blood cell precursors (erythroblasts), impaired DNA synthesis leads to nuclear maturation arrest and a prolonged S-phase. However, RNA synthesis and hemoglobin production continue normally in the cytoplasm.
• Megaloblastic Changes: This imbalance results in cells that are larger than normal (megaloblasts) because they fail to undergo the standard number of divisions before entering circulation.
• Clinical Presentation: These enlarged erythrocytes manifest as macrocytosis, characterized by an increased Mean Corpuscular Volume (MCV) and, in severe cases, megaloblastic anemia.

Bottom line

The MTHFD1 rs2236225 polymorphism destabilizes a key enzyme in the one-carbon cycle, reducing its efficiency and increasing vulnerability to folate deficiency. This deficiency impairs DNA synthesis in erythroid precursors, leading to the development of enlarged red blood cells (macrocytosis). For individuals with this variant, maintaining optimal folate status is critical to support effective DNA replication and prevent hematological abnormalities.